The company holds the rights to new delivery technologies using a bio-adhesive, adjustable dose, and fully dissolvable, non-irritant patch, which provides for a needle free, intra-oral systemic drug delivery. The conveyance technology is designed to accelerate and enhance the delivery and bioavailability of medicines and cannabis actives when compared to traditional methods of enteral administration.
The transmembrane functionality enables needle-free, transmucosal drug delivery, administering the medicine directly into the blood system while bypassing the digestive and hepatic systems, thereby increasing the bioavailability and lowering the dose required to achieve desired therapeutic effects.
The mucoadhesive film is applied on the internal mouth, and is made of multiple dosage form layers, enabling loading of different dosages on the same thin film patch.
Two or more layers of the Eluting Patch offers diverse timing of drug administration. The inner film layer is attached to the membrane providing fast release, followed by the outer film layers providing a slow and sustained release.
Each layer contains similar or different drugs, depending of the purpose of the medical treatment.
© 2018 The Greater Cannabis Company, Inc. ALL Rights Reserved